227 related articles for article (PubMed ID: 1900959)
21. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models.
Reitz RH; Mendrala AL; Guengerich FP
Toxicol Appl Pharmacol; 1989 Feb; 97(2):230-46. PubMed ID: 2922756
[TBL] [Abstract][Full Text] [Related]
22. Combining transcriptomics and PBPK modeling indicates a primary role of hypoxia and altered circadian signaling in dichloromethane carcinogenicity in mouse lung and liver.
Andersen ME; Black MB; Campbell JL; Pendse SN; Clewell HJ; Pottenger LH; Bus JS; Dodd DE; Kemp DC; McMullen PD
Toxicol Appl Pharmacol; 2017 Oct; 332():149-158. PubMed ID: 28392392
[TBL] [Abstract][Full Text] [Related]
23. The effect of an unusual workshift on chemical toxicity. I. Studies on the exposure of rats and mice to dichloromethane.
Kim YC; Carlson GP
Fundam Appl Toxicol; 1986 Jan; 6(1):162-71. PubMed ID: 3710022
[TBL] [Abstract][Full Text] [Related]
24. Dichloromethane as an inhibitor of cytochrome c oxidase in different tissues of rats.
Lehnebach A; Kuhn C; Pankow D
Arch Toxicol; 1995; 69(3):180-4. PubMed ID: 7717874
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
Evans MV; Caldwell JC
Toxicol Appl Pharmacol; 2010 May; 244(3):280-90. PubMed ID: 20153349
[TBL] [Abstract][Full Text] [Related]
26. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
Toxicol Appl Pharmacol; 1990 Mar; 102(3):497-513. PubMed ID: 2315918
[TBL] [Abstract][Full Text] [Related]
27. Effect of long-term ethanol pretreatment on the metabolism of dichloromethane to carbon monoxide in rats.
Wirkner K; Damme B; Poelchen W; Pankow D
Toxicol Appl Pharmacol; 1997 Mar; 143(1):83-8. PubMed ID: 9073595
[TBL] [Abstract][Full Text] [Related]
28. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
29. Carboxyhemoglobin formation due to carbon monoxide exposure in rats.
Benignus VA; Annau Z
Toxicol Appl Pharmacol; 1994 Sep; 128(1):151-7. PubMed ID: 8079348
[TBL] [Abstract][Full Text] [Related]
30. Reversal of carbon monoxide-cytochrome c oxidase binding by hyperbaric oxygen in vivo.
Brown SD; Piantadosi CA
Adv Exp Med Biol; 1989; 248():747-54. PubMed ID: 2551142
[TBL] [Abstract][Full Text] [Related]
31. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model.
Dankovic DA; Bailer AJ
Fundam Appl Toxicol; 1994 Jan; 22(1):20-5. PubMed ID: 8125209
[TBL] [Abstract][Full Text] [Related]
32. Effect of isoniazid or phenobarbital pretreatment on the metabolism of dihalomethanes to carbon monoxide.
Pankow D; Weise M; Hoffmann P
Pol J Occup Med Environ Health; 1992; 5(3):245-50. PubMed ID: 1490123
[TBL] [Abstract][Full Text] [Related]
33. Carbon monoxide exchanges between the human fetus and mother: a mathematical model.
Hill EP; Hill JR; Power GG; Longo LD
Am J Physiol; 1977 Mar; 232(3):H311-23. PubMed ID: 842687
[TBL] [Abstract][Full Text] [Related]
34. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats.
Dallas CE; Gallo JM; Ramanathan R; Muralidhara S; Bruckner JV
Toxicol Appl Pharmacol; 1991 Sep; 110(2):303-14. PubMed ID: 1891776
[TBL] [Abstract][Full Text] [Related]
35. Inhalation pharmacokinetics: evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios.
Andersen ME; Gargas ML; Ramsey JC
Toxicol Appl Pharmacol; 1984 Mar; 73(1):176-87. PubMed ID: 6710514
[TBL] [Abstract][Full Text] [Related]
36. A new approach for the carbon monoxide (CO) exposure diagnosis: measurement of total CO in human blood versus carboxyhemoglobin (HbCO).
Varlet V; De Croutte EL; Augsburger M; Mangin P
J Forensic Sci; 2013 Jul; 58(4):1041-6. PubMed ID: 23692308
[TBL] [Abstract][Full Text] [Related]
37. Methylene chloride: a 2-year inhalation toxicity and oncogenicity study in rats.
Nitschke KD; Burek JD; Bell TJ; Kociba RJ; Rampy LW; McKenna MJ
Fundam Appl Toxicol; 1988 Jul; 11(1):48-59. PubMed ID: 3209017
[TBL] [Abstract][Full Text] [Related]
38. Technique for accurately producing desired carboxyhemoglobin levels during rest and exercise.
Dahms TE; Horvath SM; Gray DJ
J Appl Physiol; 1975 Feb; 38(2):366-8. PubMed ID: 1120767
[TBL] [Abstract][Full Text] [Related]
39. Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model.
Andersen ME; MacNaughton MG; Clewell HJ; Paustenbach DJ
Am Ind Hyg Assoc J; 1987 Apr; 48(4):335-43. PubMed ID: 3591649
[TBL] [Abstract][Full Text] [Related]
40. In vivo binding of carbon monoxide to cytochrome c oxidase in rat brain.
Brown SD; Piantadosi CA
J Appl Physiol (1985); 1990 Feb; 68(2):604-10. PubMed ID: 2156793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
